# China's NMPA approves Nerivio for acute migraine in adults, with partner Pier 88 Health

Canonical page: https://technooptimist.io/stories/china-s-nmpa-approves-nerivio-for-acute-migraine-in-adults-with-partner-75e45e76
Date: 29 Sep 2025
About: [Theranica](https://technooptimist.io/companies/theranica.md) · [Nerivio](https://technooptimist.io/neurotech/nerivio.md)
Original source: https://www.biospace.com/press-releases/pier-88-health-and-theranica-announce-china-nmpa-approval-of-the-nerivio-ren-wearable-for-acute-treatment-of-migraine

Pier 88 Health and Theranica announced China's approval of Nerivio, the first remote electrical neuromodulation wearable for migraine approved there. The certificate was issued on 11 August 2025; the initial indication is acute treatment in adults.

## Key facts

- About 130 million people in China are estimated to have migraine
- Expansion to other indications and age groups is planned
- Key Theranica markets: US, Europe, India, South Africa and now China

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.